Hallux

Hallux

Verified
An innovative clinical stage pharmaceutical company focused on developing safe and highly effective breakthrough solutions for common infections of the toe, nail and foot.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$38—56m (Dealroom.co estimates Apr 2022.)
Orange California (HQ)
  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

$0.0

round
N/A

$0.0

round
*
N/A

$9.4m

Series A
Total Funding000k

Recent News about Hallux

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.